Latest Monoclonal antibody therapy Stories
- Fully human mAb neutralizes multiple virulence factors of S. aureus, including alpha-hemolysin LEBANON, N.H. and VIENNA, Jan.
OXFORD, England, January 14, 2015 /PRNewswire/ -- Oxford BioTherapeutics announces today that Boehringer Ingelheim has exercised an option to receive exclusive rights to
Symphogen has licensed the rights to the Selexis SUREtechnology Platform™ and SURE CHO-M Cell Line™ for the development of recombinant monoclonal antibody (MAb) mixtures for the treatment
SUZHOU, China, Dec. 8, 2014 /PRNewswire/ -- Adagene Inc.
Broad Bi-Specific Antibody Collaboration Now Includes Targets that Could Lead to New Cancer Immunotherapies INDIANAPOLIS and VANCOUVER, Oct. 22, 2014 /CNW/ - Zymeworks Inc.
SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Marco Londei, M.D.
AbGenomics raised new fund for advancing its mid-stage clinical trials LOS ALTOS, Calif., Oct.
-Enhances Capabilities for the Precision Medicine in Immuno-oncology and Autoimmune Disease Areas- LOS ANGELES and LEIPZIG, Germany, Sept. 17, 2014 /PRNewswire/ -- ImaginAb, Inc.
SHM-XEL Platform Successfully Generates Novel Therapeutic Approach to Autoimmune Disease SAN DIEGO, Sept.